NCI CCR Grand Rounds (NIH Only)
Impact of EGFR Mutations on the Treatment of Lung Cancer (NIH-Only)
Tuesday, April 12, 2005
Bruce E. Johnson, M.D., Harvard Medical School
Total Running Time: 01:01:30
RhoGDI2 - New Metastasis Suppressor in Bladder Cancer (NIH-Only)
Tuesday, April 05, 2005
Dan Theodorescu, MD, PhD, University of Virginia
Total Running Time: 01:08:53
Toward the Last Cohort (NIH-Only)
Tuesday, March 29, 2005
John Potter, M.D., Ph.D., Fred Hutchinson Cancer Research Center
Total Running Time: 01:03:26
Targeting the Myeloma Cell in its Microenvironment (NIH-Only)
Tuesday, March 22, 2005
Kenneth C. Anderson, M.D., Dana-Farber Cancer Institute
Total Running Time: 01:16:49
Roadside to Bedside: Natural Products Providing Path to Therapeutic Targets (NIH-Only)
Tuesday, March 08, 2005
Peter M. Blumberg, Ph.D., NCI
Total Running Time: 01:08:56
Keratinocyte Growth Factor: from Basic Research to Clinical Application (NIH-Only)
Tuesday, March 01, 2005
Jeffrey S. Rubin, M.D., Ph.D., NCI
Total Running Time: 01:01:41
Can the Angiogenic Switch be Prevented in Human Cancer? (NIH-Only)
Tuesday, October 05, 2004
Judah Folkman, M.D., Children's Hospital Boston
Total Running Time: 01:06:14
Studying Cancer Families to Identify Kidney Cancer Genes (NIH-Only)
Tuesday, January 22, 2002
Berton Zbar, M.D.
Total Running Time: 00:42:14
Winning the War Against Ovarian Cancer: New Insights with Regard to Prevention (NIH-Only)
Tuesday, January 08, 2002
Gustavo Rodriguez, M.D.
Total Running Time: 01:04:08
